Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06741527 · ClinicalTrials.gov registry record · NA
Integrity Implant System Post Market Clinical Follow-Up Study
A NA study of Rotator Cuff Tears of the Shoulder, sponsored by Anika Therapeutics.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 6
- Study locations
NCT06741527 is a NA study of Rotator Cuff Tears of the Shoulder that is actively recruiting participants, run by Anika Therapeutics. The registered enrollment target is 150 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT06741527, a NA study of Rotator Cuff Tears of the Shoulder, is actively recruiting participants, sponsored by Anika Therapeutics.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 6
- Study locations
Study Summary
The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).
Conditions Studied
Interventions
- DEVICE Integrity Implant System
Study Locations (6)
Florida
- Foundation for Orthopaedic Research and Education - Tampa
Indiana
- Central Indiana Orthopaedics - Fishers
Maryland
- Towson Orthopaedic Associates/University of Maryland St. Joseph's Medical Center - Towson
New Jersey
- Virtua Health - Marlton
South Carolina
- Steadman Hawkins Clinic of the Carolinas - Greenville
Tennessee
- Campbell Clinic - Germantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2027-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06741527
The ClinicalTrials.gov registry entry for NCT06741527 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anika Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rotator Cuff Tears of the Shoulder appearing as the primary indexed condition, and to 1 intervention - of which Integrity Implant System is the first listed.
NCT06741527 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Florida, Indiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT06741527 about?
NCT06741527 is a clinical study titled "Integrity Implant System Post Market Clinical Follow-Up Study". The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).
What is the current status of trial NCT06741527?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-02-01. Estimated completion is 2027-10.
What conditions does trial NCT06741527 study?
This clinical trial studies the following conditions: Rotator Cuff Tears of the Shoulder.
What interventions are being tested in trial NCT06741527?
The interventions under investigation include: Integrity Implant System (DEVICE).
Who is sponsoring clinical trial NCT06741527?
This trial is sponsored by Anika Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06741527 being conducted?
This trial has 6 study locations across Florida, Indiana, Maryland, New Jersey, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tears of the Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.